This site needs JavaScript to work properly. Please enable it to take advantage of the complete set of features!

Skip to main page content

Add to Collections

Your saved search

Name of saved search:

Search terms:

Test search terms

Would you like email updates of new search results?

Yes
No

Email: (change)

Frequency:

Which day?

Which day?

Report format:

Send at most:

Send even when there aren't any new results

Optional text in email:

Your RSS Feed

Review

. 1998 Jun;101(3):399-406.

doi: 10.1046/j.1365-2141.1998.00726.x.

Iron chelators for thalassaemia

C Hershko¹, A M Konijn, G Link

Affiliations

PMID: 9633877
DOI: 10.1046/j.1365-2141.1998.00726.x

Review

Iron chelators for thalassaemia

C Hershko et al. Br J Haematol. 1998 Jun.

. 1998 Jun;101(3):399-406.

doi: 10.1046/j.1365-2141.1998.00726.x.

Authors

C Hershko¹, A M Konijn, G Link

Affiliation

¹ Department of Medicine, Shaare Zedek Medical Centre, Jerusalem, Israel.

PMID: 9633877
DOI: 10.1046/j.1365-2141.1998.00726.x

No abstract available

PubMed Disclaimer

Similar articles

Effective new treatments of iron overload in thalassaemia using the ICOC combination therapy protocol of deferiprone (L1) and deferoxamine and of new chelating drugs.
Kontoghiorghes GJ, Kolnagou A. Kontoghiorghes GJ, et al. Haematologica. 2006 Jun;91(6 Suppl):ELT04. Haematologica. 2006. PMID: 16785141
Pharmacotherapy of iron overload in thalassaemic patients.
Ceci A, Felisi M, De Sanctis V, De Mattia D. Ceci A, et al. Expert Opin Pharmacother. 2003 Oct;4(10):1763-74. doi: 10.1517/14656566.4.10.1763. Expert Opin Pharmacother. 2003. PMID: 14521486 Review.
Advances in iron overload therapies. prospects for effective use of deferiprone (L1), deferoxamine, the new experimental chelators ICL670, GT56-252, L1NA11 and their combinations.
Kontoghiorghes GJ, Eracleous E, Economides C, Kolnagou A. Kontoghiorghes GJ, et al. Curr Med Chem. 2005;12(23):2663-81. doi: 10.2174/092986705774463003. Curr Med Chem. 2005. PMID: 16305464 Review.
Iron chelation with oral deferiprone in patients with thalassemia.
Cohen AR, Martin MB. Cohen AR, et al. N Engl J Med. 1998 Dec 3;339(23):1713-4. doi: 10.1056/nejm199812033392320. N Engl J Med. 1998. PMID: 9867542 No abstract available.
The effectiveness of deferiprone in thalassemia.
Dogherty P, Einarson T, Koren G, Sher G. Dogherty P, et al. Blood. 1997 Jul 15;90(2):894. Blood. 1997. PMID: 9226195 No abstract available.

See all similar articles

Cited by

Role of Metal Cations of Copper, Iron, and Aluminum and Multifunctional Ligands in Alzheimer's Disease: Experimental and Computational Insights.
Puentes-Díaz N, Chaparro D, Morales-Morales D, Flores-Gaspar A, Alí-Torres J. Puentes-Díaz N, et al. ACS Omega. 2023 Jan 25;8(5):4508-4526. doi: 10.1021/acsomega.2c06939. eCollection 2023 Feb 7. ACS Omega. 2023. PMID: 36777601 Free PMC article. Review.
Fibroblast involvement in soft connective tissue calcification.
Ronchetti I, Boraldi F, Annovi G, Cianciulli P, Quaglino D. Ronchetti I, et al. Front Genet. 2013 Mar 5;4:22. doi: 10.3389/fgene.2013.00022. eCollection 2013. Front Genet. 2013. PMID: 23467434 Free PMC article.
Desferrioxamine mesylate for managing transfusional iron overload in people with transfusion-dependent thalassaemia.
Fisher SA, Brunskill SJ, Doree C, Gooding S, Chowdhury O, Roberts DJ. Fisher SA, et al. Cochrane Database Syst Rev. 2013 Aug 21;2013(8):CD004450. doi: 10.1002/14651858.CD004450.pub3. Cochrane Database Syst Rev. 2013. PMID: 23963793 Free PMC article.
Iron overload in patients with myelodysplastic syndromes.
Jensen PD. Jensen PD. Curr Hematol Malig Rep. 2007 Feb;2(1):13-21. doi: 10.1007/s11899-007-0003-5. Curr Hematol Malig Rep. 2007. PMID: 20425384 Review.
Ineffective erythropoiesis in β -thalassemia.
Ribeil JA, Arlet JB, Dussiot M, Moura IC, Courtois G, Hermine O. Ribeil JA, et al. ScientificWorldJournal. 2013 Mar 28;2013:394295. doi: 10.1155/2013/394295. Print 2013. ScientificWorldJournal. 2013. PMID: 23606813 Free PMC article. Review.

See all "Cited by" articles

Publication types

Actions
Actions

MeSH terms

Actions
Actions
Actions
Actions
Actions
Actions
Actions
Actions
Actions
Actions
Actions
Actions
Actions
Actions
Actions
Actions

Substances

Actions
Actions
Actions
Actions
Actions
Actions
Actions
Actions
Actions

LinkOut - more resources

Full Text Sources
- Ovid Technologies, Inc.
- Wiley
Other Literature Sources
- The Lens - Patent Citations Database
Medical
- MedlinePlus Health Information